View Older Stories View More Recent Stories

May 4, 2017 08:50AM Maxim Group Starts New Age Beverages Corp (NBEV) at Buy
May 4, 2017 08:50AM Maxim Group Upgrades The KEYW Holding Corporation (KEYW) to Buy
May 4, 2017 08:09AM UPDATE: Maxim Group Starts National Beverage (FIZZ) at Sell, Overvalued Stock, Corp. Governance Riddled With Red Flags
May 3, 2017 08:10AM Maxim Group Downgrades Potbelly Corp (PBPB) to Hold
May 1, 2017 11:26PM Agility Health Reports 2016 Financial Results
May 1, 2017 06:29PM Ember Therapeutics, Inc. Announces Engagement of Maxim Group LLC to Provide Strategic Advisory Services
May 1, 2017 05:01PM ContraVir Pharmaceuticals Announces Closing of Public Offering of Common Stock and Warrants
May 1, 2017 11:13AM Æterna Zentaris (AEZS) PT Lowered to $2 at Maxim Group, Keeps 'Buy'; Value in Macrilen Now
Apr 27, 2017 09:00AM ROTH Capital Partners Announces the Addition of Eric B. Cheng, Managing Director, Head of Healthcare Investment Banking
Apr 26, 2017 04:05PM Adamis Pharmaceuticals Announces Closing of Public Offering of Common Stock and Exercise of Over-Allotment Option in Full
Apr 25, 2017 09:03AM ContraVir Pharma (CTRV) Prices Shares/Warrant Offering at $1
Apr 25, 2017 09:00AM ContraVir Pharmaceuticals Announces Pricing of Public Offering of Common Stock and Warrants
Apr 24, 2017 11:25AM Maxim Group Reiterates Buy Rating and $10 PT on CytoSorbents (CTSO) Following $1M Non-Dilutive Funding Awarded by DoD
Apr 21, 2017 01:43PM Maxim Group Maintains Hold Rating on Gilead Sciences (GILD) Following Presentation of Positive GS-0976 Data for NASH
Apr 21, 2017 09:13AM Adamis Pharmaceuticals (ADMP) Prices 4.3M Shares at $3.50
Apr 21, 2017 09:13AM Adamis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Apr 21, 2017 08:25AM Maxim Group Downgrades COPsync (COYN) to Hold
Apr 20, 2017 05:05PM Maxim Group Starts GW Pharma (GWPH) at Buy
Apr 20, 2017 04:05PM Adamis Pharmaceuticals (ADMP) to Offer Common Stock
Apr 20, 2017 04:01PM Adamis Pharmaceuticals Announces Proposed Public Offering of Common Stock
Apr 20, 2017 01:15PM 2017 Q1 PIPEs Market Eclipses Last Year's First Quarter
Apr 20, 2017 12:24PM Maxim Group Reiterates Buy Rating and $7 PT on Agenus (AGEN); 'AGEN2034 (Anti-PD-1) Moves into the Clinic'
Apr 20, 2017 09:35AM Whitestone REIT Announces Pricing of Public Offering of Common Shares
Apr 20, 2017 09:29AM Pre-Open Movers 04/20: (IMNP) (SCSS) (KCG) Higher; (PLXS) (WR) (PM) Lower (more...)
Apr 20, 2017 08:19AM Interpace Diagnostics (IDXG) Converts All Remaining Long-Term Secured Outstanding Debt into Common Stock
Apr 20, 2017 08:08AM Interpace Diagnostics Eliminates Long Term Secured Debt
Apr 20, 2017 07:42AM UPDATE: Maxim Group Starts Nxt-ID, Inc. (NXTD) at Buy, Says "Positioned to Benefit From Changes in Payments Industry"
Apr 19, 2017 05:51PM After-Hours Stock Movers 04/19: (SCSS) (SLM) (CSX) Higher; (PLXS) (WR) (EBAY) Lower (more...)
Apr 19, 2017 04:56PM Whitestone REIT (WSR) Commences 8.1M Share Common Stock Offering
Apr 19, 2017 04:55PM Whitestone REIT Announces Proposed Offering of Common Shares
Apr 19, 2017 02:07PM Maxim Group Maintains Hold Rating on ContraFect (CFRX); New CF-301 Data to be Presented at ECCMID
Apr 19, 2017 08:30AM CytoSorbents 2017 - Propelling the Company to the "Next Level"
Apr 18, 2017 09:00AM Aftermaster Partners With Maxim Group LLC For Investment Banking Services
Apr 17, 2017 07:48AM Maxim Group Reiterates Buy Rating and $4 PT on CASI Pharmaceuticals (CASI); Patient Enrollment for Ph2 ENMD-2076 Study is Complete
Apr 13, 2017 02:32PM Maxim Group Maintains Buy Rating and $6 PT on Intellipharmaceutics (IPCI) Following 1Q Results Miss; 'Focused on Rexista Now'
Apr 13, 2017 02:22PM Maxim Group Reiterates Buy Rating and $21 PT on Sucampo Pharmaceuticals (SCMP); 'We See Upside in the Stock'
Apr 12, 2017 12:30PM Maxim Group Upgrades TrovaGene (TROV) to Buy
Apr 12, 2017 11:58AM TICC Capital Corp. Completes Public Offering of $64,370,225 6.50% Notes Due 2024
Apr 12, 2017 11:49AM Virtual Health Partners Closes Series A Financing
Apr 12, 2017 08:38AM PlacementTracker Publishes Q1 2017 Private Placement Market League Tables
Apr 11, 2017 08:46AM Cytori Therapeutics (CYTX) Prices 8.6M Common Stock Offering at $1.10/Share
Apr 11, 2017 08:45AM Cytori Announces Pricing of $9.5M Public Offering of Common Stock
Apr 11, 2017 07:00AM OneSoft Subsidiary, OneBridge Solutions Inc., Presents at Banff 2017 Pipeline Workshop; OneSoft Presents at Microcap Investors Conference in New York City
Apr 11, 2017 06:26AM Naked Brand (NAKD) Raises $5.5M from ATM Program; Amends LOI with Bendon
Apr 11, 2017 06:15AM Naked Brand Group Announces $5.5 Million in Gross Proceeds from Completed At The Market Offering; Amends LOI with Bendon to Reflect $34 Million in Expected Balance Sheet Improvements
Apr 10, 2017 04:02PM Cytori Therapeutics (CYTX) to Offer Common Stock via Maxim Group
Apr 10, 2017 04:01PM Cytori Announces Proposed Public Offering of Common Stock
Apr 10, 2017 02:13PM Maxim Group Reiterates Buy Rating and $14 PT on Abeona Therapeutics (ABEO) Ahead of ABO-102 Incremental Data Presentation on 4/11
Apr 10, 2017 11:20AM Maxim Group Reiterates Buy Rating and $6 PT on Intellipharmceutics (IPCI) Following Lawsuit from Purdue Pharma Over Rexista
Apr 10, 2017 07:40AM Maxim Group Reiterates Buy Rating and $14 PT on Mesoblast Limited (MESO); 'Successful Interim Analysis of Efficacy Endpoint in Pivotal Heart Failure Trial'
View More Recent Stories View Older Stories